STOCK TITAN

Morgan Stanley SEC Filings

MS NYSE

Welcome to our dedicated page for Morgan Stanley SEC filings (Ticker: MS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Morgan Stanley’s disclosures are a treasure trove of information on everything from trading Value-at-Risk to the health of its $4T wealth-management franchise. But finding those details inside a 300-page report is tedious. This page curates every filing the firm submits to EDGAR, then layers Stock Titan’s AI so Morgan Stanley SEC filings are explained simply.

Need the latest Morgan Stanley quarterly earnings report 10-Q filing or an Morgan Stanley 8-K material events explained summary? We post them in real time and generate concise AI-powered breakdowns of segment revenue, capital ratios, and liquidity buffers. Curious about management’s trading activity? Our alerts track Morgan Stanley insider trading Form 4 transactions and show Morgan Stanley Form 4 insider transactions real-time, highlighting patterns before they hit the news. When proxy season arrives, the platform pinpoints pay packages inside the Morgan Stanley proxy statement executive compensation section—no more hunting through exhibits.

Professionals use these tools to:

  • Compare quarter-over-quarter margins with a click using our Morgan Stanley earnings report filing analysis
  • Monitor Morgan Stanley executive stock transactions Form 4 for buy-sell trends
  • Read a Morgan Stanley annual report 10-K simplified summary that clarifies risk factors, legal reserves, and capital plans
  • Ask natural questions like “understanding Morgan Stanley SEC documents with AI” and receive instant answers

Whether you’re gauging deal pipelines, stress-testing balance sheets, or assessing leadership’s confidence, our AI-powered summaries, expert context, and real-time updates turn raw filings into actionable knowledge—faster than opening a PDF.

Rhea-AI Summary

Regulus Therapeutics Inc. ("Regulus") has filed a Post-Effective Amendment No. 1 to 20 previously effective Form S-8 registration statements. The amendment formally terminates the registration of all remaining, unsold shares of Regulus common stock that had been set aside for issuance under a variety of equity incentive, inducement and employee stock-purchase plans dating from 2009 through 2025. The affected plans include the 2009 and 2012 Equity Incentive Plans, multiple Employee Stock Purchase Plans (2012 & 2022), the 2019 Equity Incentive Plan and the 2021 Inducement Plan, among others.

The filing follows the consummation of Regulus’ merger with Novartis AG on 25 June 2025, executed under the 29 April 2025 Agreement and Plan of Merger. Redwood Merger Sub Inc., a wholly-owned Novartis subsidiary, was merged into Regulus, with Regulus surviving as a wholly-owned subsidiary of Novartis. Consequently, Regulus has ceased all public offerings of its securities, making the S-8 registrations unnecessary.

Key implications for investors:

  • Any options or rights that remained unexercised under the listed equity plans will no longer be eligible for issuance of new Regulus common shares under the Securities Act.
  • The deregistration is an administrative step that typically follows completion of an acquisition; it does not disclose merger consideration, exchange ratios, or post-merger integration plans.
  • The filing confirms that Regulus is no longer an independent, Exchange-Act reporting company; future disclosures will occur through Novartis, if material.

No financial statements, earnings data, or forward-looking statements are included in the document.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Morgan Stanley Finance has announced Worst-of SPX, NDX and RTY Trigger PLUS securities due August 5, 2030. These structured notes offer leveraged exposure to the worst-performing index among the S&P 500, Nasdaq-100, and Russell 2000 indices.

Key features include:

  • Maximum payment at maturity: 176% to 181% of principal ($1,760 to $1,810 per security)
  • Leverage factor: 400%
  • Downside threshold: 70% of initial level
  • Estimated value: $944.10 per security

Notable risks include no principal protection, limited appreciation potential, and exposure to the worst-performing index. The securities don't pay interest and are subject to Morgan Stanley's credit risk. The payment at maturity will be determined solely by the worst-performing underlier's value on July 31, 2030. If any underlier declines more than 30% from its initial level, investors will be fully exposed to the downside of the worst performer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Morgan Stanley Finance has announced SX5E Market-Linked Notes due August 5, 2030, offering investors exposure to the EURO STOXX 50® Index with enhanced upside potential. Key features include:

  • A 130% to 135% participation rate in the index's positive performance
  • Principal protection against negative index performance
  • Estimated value of $952.00 per note
  • 5-year maturity with observation date on July 31, 2030

The notes' payment structure offers asymmetric returns: investors receive 130-135% of any positive index performance while being protected against losses, maintaining the $1,000 principal even if the index declines. Notable risks include credit risk of Morgan Stanley, no interim interest payments, and limited secondary market liquidity. The notes are guaranteed by Morgan Stanley and will trade under CUSIP 61778NAV3.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

Morgan Stanley Finance LLC has announced Market-Linked Notes due August 5, 2030, based on the performance of the EURO STOXX 50 Index. The notes, fully guaranteed by Morgan Stanley, are being offered at $1,000 per note with an estimated value of approximately $952.00.

Key features include:

  • No interest payments over the term
  • Principal protection at maturity regardless of index performance
  • Participation rate of 130% to 135% in index gains
  • If final index level exceeds initial level, investors receive principal plus enhanced upside participation
  • If final index level is equal to or below initial level, investors receive only principal

Notable risks include credit risk of Morgan Stanley, no interest payments, and value determined solely by index performance on the observation date (July 31, 2030). The notes will not be listed on any securities exchange and involve costs that reduce their economic terms compared to direct index investment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Morgan Stanley Finance LLC, guaranteed by Morgan Stanley, plans to issue market-linked notes tied to the EURO STOXX 50 Index (SX5E). The notes offer 114%-119% upside participation on any positive index performance observed on July 31 2029, with full principal repayment at maturity even if the index declines. Key terms include a $1,000 face value, pricing on July 31 2025, and maturity on August 3 2029 (4-year term). The preliminary estimated value is $958.80 (≈95.9% of face), reflecting issuance and hedging costs.

Key structural features

  • No periodic coupons; all return realized at maturity.
  • Amount payable depends solely on index level at the single observation date; interim movements are irrelevant.
  • Notes will not be listed, and secondary liquidity may be limited.
  • Credit exposure to Morgan Stanley; MS Finance LLC is a wholly owned funding vehicle without independent assets.

Principal risk highlights

  • Investors may earn only principal if SX5E is flat or negative.
  • The 4.1% issue-price premium versus estimated value creates negative yield if held to maturity without index appreciation.
  • Market value can be volatile, influenced by MS credit spreads and trading in related instruments.
  • Investors may incur taxable income annually under U.S. OID rules.

Overall, the product suits investors seeking European equity exposure with principal protection and are comfortable with MS credit risk and the lack of interim income.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Morgan Stanley Finance has announced Market-Linked Notes due August 5, 2030, tied to the S&P 500® Futures Excess Return Index (SPXFP). Key features include:

  • Participation rate of 128% to 133% in the index's positive performance
  • Principal protection against negative index performance
  • Estimated value of $954.30 per note
  • 5-year maturity (2025-2030)

The notes offer enhanced upside potential while maintaining principal protection, with payments at maturity ranging from $1,000 (minimum) to potentially higher returns based on index performance. For example, a 40% index increase would yield a 51.2% return (at 128% participation rate).

Key risks include credit risk of Morgan Stanley, no interest payments, limited secondary market trading, and potential tax implications prior to maturity. The notes' value may be affected by market factors, and the final payment depends solely on the index's performance at maturity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

Morgan Stanley Finance LLC announces Worst-of SPX and SX5E Dual Directional Buffered PLUS securities due August 5, 2030. Key features include:

  • Underliers: S&P 500® Index (SPX) and EURO STOXX 50® Index (SX5E)
  • Leverage factor: 212% to 227%
  • Buffer amount: 20% with 80% maximum loss
  • Absolute return participation rate: 50%
  • Estimated value: $953.00 per security (±$55.00)

The payment at maturity will be based on the worst-performing underlier's performance. Notable risks include: no interest payments, exposure to both indices' price risks, credit risk of Morgan Stanley, and limited secondary market trading. The security offers leveraged upside potential with some downside protection through the buffer, making it suitable for investors seeking enhanced returns while accepting some market risk.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Morgan Stanley Finance has announced URA Buffered Jump Securities due August 13, 2026, linked to the Global X Uranium ETF (URA). Key features include:

  • Fixed upside payment of $132.50 per security (13.25% return) if the underlier is flat or up at maturity
  • 25% downside buffer protecting against first 25% of losses
  • Maximum loss capped at 75% of principal
  • Estimated value of $965.30 per security

The securities offer conditional downside protection while maintaining upside potential in the uranium sector. Notable risks include: credit risk of Morgan Stanley, limited appreciation potential, no interim payments, and market price influenced by unpredictable factors. The product particularly targets investors seeking exposure to the uranium sector with partial downside protection.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Morgan Stanley Finance LLC has announced SPX Market-Linked Notes due January 16, 2030, offering investors exposure to S&P 500® Index performance with principal protection. Key features include:

  • 100% participation rate in index gains up to a maximum payment of $1,400 per note (140% of principal)
  • Principal protection against market downside - minimum payment of $1,000 per note regardless of index performance
  • Notes are priced at $973.90 estimated value per note
  • 4.5-year term from July 11, 2025 pricing date to January 16, 2030 maturity

Key risks include: no interest payments, limited upside potential due to payment cap, credit risk of Morgan Stanley, limited secondary market liquidity, and potential required tax recognition before maturity. The notes' value will be determined solely by the S&P 500® Index level on the January 11, 2030 observation date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

Morgan Stanley Finance has announced SPX Buffered PLUS Notes due January 16, 2030, offering investors exposure to the S&P 500 Index with enhanced features. Key terms include:

  • Maximum Return: 54% (capped at $1,540 per $1,000 principal)
  • Leverage Factor: 150% participation in index gains
  • Downside Protection: 10% buffer against losses
  • Estimated Value: $969.10 per security

The structured note offers enhanced upside potential up to the cap while providing partial protection against market declines. Investors maintain full principal if the S&P 500 declines by 10% or less, with one-for-one losses beyond the buffer. Key risks include credit risk of Morgan Stanley, limited secondary market liquidity, and capped upside potential. The notes do not provide dividend payments or direct index exposure.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

What is the current stock price of Morgan Stanley (MS)?

The current stock price of Morgan Stanley (MS) is $140.69 as of June 28, 2025.

What is the market cap of Morgan Stanley (MS)?

The market cap of Morgan Stanley (MS) is approximately 212.9B.

What are Morgan Stanley's primary business segments?

Morgan Stanley operates across three primary segments: institutional securities, wealth management, and investment management. Each segment addresses specific client needs ranging from corporate financial advisory to personalized wealth planning.

How does Morgan Stanley generate its revenue?

The firm generates revenue through a diversified business model that includes fees from advisory services, commissions from executions in capital markets, and asset management fees from tailored investment solutions. This diversity helps spread risk and ensures stability.

What is the global presence of Morgan Stanley?

Morgan Stanley maintains operations in numerous countries, which allows it to engage with both developed and emerging markets. Its international presence supports a broad client base and ensures regional market insights are integrated into its service offerings.

How does Morgan Stanley differentiate itself from its competitors?

The firm differentiates itself by combining a rich historical legacy with advanced financial technologies and a client-centric approach. Its integrated business model and expertise in risk management create a balanced strategy that caters to a diverse range of financial needs.

What type of clients does Morgan Stanley serve?

Morgan Stanley serves a wide array of clients including corporations, governments, institutional investors, and individual investors. This diverse clientele benefits from its deep expertise in investment banking, wealth management, and investment management.

What risk management strategies does Morgan Stanley employ?

Morgan Stanley employs comprehensive risk management frameworks that address market, credit, and operational risks. The firm aligns its strategies with global regulatory standards and employs advanced analytics to ensure transparency and stability in its operations.

How does Morgan Stanley maintain its expertise in the financial industry?

The firm continually invests in research, technology, and talent development. Its collaboration with industry experts and academic institutions enables Morgan Stanley to stay ahead of market trends and to provide insightful, data-driven analysis to its clients.

What factors contribute to Morgan Stanley's competitive positioning in the market?

A combination of a diversified business portfolio, a strong global presence, innovative technological integration, and rigorous risk management practices contribute to Morgan Stanley's competitive edge. These factors collectively enable the firm to adapt and respond effectively to market challenges.
Morgan Stanley

NYSE:MS

MS Rankings

MS Stock Data

212.91B
1.22B
23.64%
62.12%
0.89%
Capital Markets
Security Brokers, Dealers & Flotation Companies
Link
United States
NEW YORK